Replimune Group, Inc. — Director's Dealing 2019

Dec 12, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2019-12-09

Reporting Person: Franchi Jean M. (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-09	Employee Stock Option (right to buy)	$14.08	A	180000	Acquired	2029-12-09	Common Stock (180000)	Direct

Footnotes

F1: 25% of the shares underlying this stock option vest on December 9, 2020, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter.